Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney

This publication has 28 references indexed in Scilit:

• Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.
  Hypertension, 1981
• Role of Prostaglandin in the Antihypertensive Mechanism of Captopril in Low Renin Hypertension
  Clinical Science, 1980
• Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney [letter]
  Published by Wiley ,1980
• Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain
  European Journal of Pharmacology, 1980
• Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients
  Annals of Internal Medicine, 1979
• Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
  Progress in Cardiovascular Diseases, 1978
• Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man
  New England Journal of Medicine, 1978
• The kinins
  Biochemical Pharmacology, 1976
• Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism
  Nature, 1976
• Radioimmunoassay of Prostaglandins F_α, E₁ and E₂ in Human Plasma
  European Journal of Clinical Investigation, 1975